Blog / Archives
Bull Market Rolls On And Biotech Sector Hits New All Time Highs
BioBubble with No Trouble? Another green screen today with the usual suspects running in Rayno Biopharmaceuticals helped by the Bank of America Health Care Conference. Alexion (ALXN) up 2.86%,...
VRML Soars 40% On Equity Infusion: Biomarker Face-Off Redux with BGMD,RGDX
Vermillion Gets Equity Infusion from Oracle Partners, Others: VRML Soars 36% By popular demand and continuing interest in three emerging micro-cap stocks we are updating coverage. This is triggered...
Oncology Pipeline Analysis from Linda Pullan: ASCO Primer
ASCO Meeting Coming Up May 31 With the ASCO Meeting coming up at the end of the month, we are pleased to provide oncology pipeline data from Linda Pullan. There was a lot of interest on this WEB...
Rayno Life Science Diagnostics and Tools: Big Winners ABAX,ILMN,NEOG,QDEL,TMO
Rayno Diagnostics and Tools-Awaiting Q1 Results Many Rayno Diagnostics and Tools stocks have made new highs recently despite the sector being less frothy than biopharmaceuticals. These stocks are...
Rayno Life Science Update: A Little Profit Taking With Sector Up 30% YTD
Rayno Biopharma Portfolio We are still cautious on adding new biotech positions except stocks that were mentioned last month (see Alkermes ALKS, Array ARRY and Achillion ACHN). Many biotech MO...
Targeted Therapy and Diagnostic Biomarker Studies and Services 3/3/13 Update GHDX
Genomic Health Up 5% on Higher Q1 Revenues An article in the New York Times today (May 2) by Gina Kolata reviewed studies that affirmed the genetic basis of cancer. Genetic analysis of hundreds of...
Bit of a Blah Risk-Off Day- Except Regeneron (REGN) Up 14%
Regeneron (REGN) Up 30 Points On Allergan Delays For Vision Loss Drug As news came out from an Allergan (AGN $98.5) off 12%, conference call that their vision loss drug would be delayed, Regeneron...
Frothy Biotechs Hit By Amgen Earnings- Reiterate Caution
Biotech Sector Off All Time Highs This Week-IBB Down 2.5% The biotech melt-up that coincided with the surprising Vertex (VRTX) 60% move on April 19 has run its course and the IBB is now 7 pts off...
Rayno Life Science and Tools: Performance Summary April 21 YTD
A Great Quarter for Many Tools and Diagnostic Stocks The tools and diagnostics sector usually underperforms biopharmaceuticals because the companies are more tethered to deal news and fundamentals....
BIO Meeting in Chicago Next Week
I am at BIO next week and will probably not be posting for several days: 2013 BIO International Convention Here are some of the key sessions: Schedule at a Glance | 2013 BIO International...